![glp 1 conference 3rd GLP-1-Based Therapeutics Summit 2026 [04/14/26] GLP-1 Receptor Agonists in Flavor:Variety pack Targeted_Treatments](https://media.thebostoncalendar.com/images/q_auto,fl_lossy/v1764586403/xfhrsgzqsy7gc1nv7hdi/3rd-glp-1-based-therapeutics-summit-2026.jpg)
![glp 1 conference 3rd GLP-1-Based Therapeutics Summit 2026 [04/14/26] GLP-1 Receptor Agonists in Flavor:Variety pack Targeted_Treatments](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=10164275273630202)
![glp 1 conference 3rd GLP-1-Based Therapeutics Summit 2026 [04/14/26] GLP-1 Receptor Agonists in Flavor:Variety pack Targeted_Treatments](https://plexusdx.com/cdn/shop/articles/b5_3f18277c-2527-4ab5-baac-712f07c88a52.jpg?v=1779098206&width=4608)
![glp 1 conference 3rd GLP-1-Based Therapeutics Summit 2026 [04/14/26] GLP-1 Receptor Agonists in Flavor:Variety pack Targeted_Treatments](https://plexusdx.com/cdn/shop/articles/p14_8d44e68a-7264-4cf2-aafc-acf66a0910b2.jpg?v=1779098201&width=4608)
Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
glp 1 conference 3rd GLP-1-Based Therapeutics Summit 2026 [04/14/26] GLP-1 Receptor Agonists in Flavor:Variety pack Targeted_Treatments
GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use | Current Obesity Reports | Springer Nature Link
F., Holst, J
Targeted_Treatments
Flavor:Variety pack
The SURPASS trial series spans five major trials with combined enrollment exceeding 10,000 participants, establishing the most comprehensive GLP-1 agonist evidence base in existence
-(1).png?sfvrsn=c236e848_3)
US$ 26.58
US$ 28.33
US$ 23.80
